Labile quaternary ammonium salts useful in binding bile acids in warm-blooded animals
AssigneeINTERNx Research Corporation
InventorNicolae S. Bodor
Life of this patent
Estimating the term…
Loading patent…
AssigneeINTERNx Research Corporation
InventorNicolae S. Bodor
Estimating the term…
Free and conjugated bile acids are effectively bound in warm-blooded animals by administering thereto, a therapeutically effective bile acid binding amount of a quaternary ammonium compound having the formula: ##STR1## wherein N represents a tertiary open chain or cyclic aliphatic amine; wherein N represents an unsaturated amine; wherein R represents a member selected from the group consisting of a hydrogen atom, a C.sub.1 -C.sub.20 open chain or cyclo alkyl group, a C.sub.1 -C.sub.20 alkoxyalkyl group, a C.sub.1 -C.sub.20 alkanoyloxyalkyl group, a C.sub.1 -C.sub.20 haloalkyl group, a C.sub.1 -C.sub.20 carboxyalkyl group, an aryl group, and a substituted aryl group, whose substituents are selected from the group consisting of a halogen atom, an O-C.sub.1 -C.sub.4 alkyl group, an O-C.sub.1 -C.sub.8 alkanoyl group, a nitro group, a carboxyl group, and a carboethoxy group; wherein R.sub.1, which may be the same or different, represents any member defined by R above with the proviso that R cannot be a hydrogen atom, a ##STR2## WHEREIN R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are each selected from the group consisting of a hydrogen atom, a methyl group or an ethyl group, a C.sub.0 -C.sub.22 straight or branched ##STR3## WHEREIN N IN EACH OCCURRENCE AND M REPRESENTS AN INTEGER OF FROM 0 TO 22, AN ##STR4## WHEREIN A represents a C.sub.0 -C.sub.22 straight or branched alkyl group as above or a --(CH.sub.2 CH.sub.2 O).sub.p group, wherein the p represents an integer of from 0 to 22, and the residue of any naturally occurring bile acid or synthetic derivative thereof; and wherein X.sup.- represents a halogen atom or any other organic or inorganic monovalent anion are disclosed. These components are relatively nontoxic and substantially bind bile acids in warm-blooded animals and thus reduce the ulcerogenic symptoms exhibited by those characterized as being ulcerprone.
A method for substantially binding free and conjugated bile acids in a warm-blooded animal characterized as being ulcer-prone which comprises orally administering thereto, a therapeutically effective bile acid binding amount of a compound having the formula:
Dependencies are inferred from the claim text.